Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Oaktree Acquisition (OAC) Competitors

OAC vs. TDOC, AUNA, SBC, AIRS, LFMD, TOI, SHLT, CCM, HIMS, and SWTX

Should you be buying Oaktree Acquisition stock or one of its competitors? The main competitors of Oaktree Acquisition include Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), AirSculpt Technologies (AIRS), LifeMD (LFMD), Oncology Institute (TOI), SHL Telemedicine (SHLT), Concord Medical Services (CCM), Hims & Hers Health (HIMS), and SpringWorks Therapeutics (SWTX).

Oaktree Acquisition vs.

Oaktree Acquisition (NYSE:OAC) and Teladoc Health (NYSE:TDOC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, community ranking, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

Oaktree Acquisition has higher earnings, but lower revenue than Teladoc Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree AcquisitionN/AN/A$1.15MN/AN/A
Teladoc Health$2.57B0.60-$220.37M-$5.88-1.50

Teladoc Health has a consensus target price of $11.26, indicating a potential upside of 27.30%. Given Teladoc Health's stronger consensus rating and higher possible upside, analysts clearly believe Teladoc Health is more favorable than Oaktree Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Teladoc Health
0 Sell rating(s)
11 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.39

47.6% of Oaktree Acquisition shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 1.0% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Teladoc Health had 21 more articles in the media than Oaktree Acquisition. MarketBeat recorded 21 mentions for Teladoc Health and 0 mentions for Oaktree Acquisition. Teladoc Health's average media sentiment score of 0.62 beat Oaktree Acquisition's score of 0.00 indicating that Teladoc Health is being referred to more favorably in the news media.

Company Overall Sentiment
Oaktree Acquisition Neutral
Teladoc Health Positive

Oaktree Acquisition has a beta of 0.17, suggesting that its share price is 83% less volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

Oaktree Acquisition has a net margin of 0.00% compared to Teladoc Health's net margin of -37.91%. Oaktree Acquisition's return on equity of 0.00% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree AcquisitionN/A N/A N/A
Teladoc Health -37.91%-10.06%-4.86%

Teladoc Health received 680 more outperform votes than Oaktree Acquisition when rated by MarketBeat users. However, 100.00% of users gave Oaktree Acquisition an outperform vote while only 62.95% of users gave Teladoc Health an outperform vote.

CompanyUnderperformOutperform
Oaktree AcquisitionOutperform Votes
3
100.00%
Underperform Votes
No Votes
Teladoc HealthOutperform Votes
683
62.95%
Underperform Votes
402
37.05%

Summary

Teladoc Health beats Oaktree Acquisition on 10 of the 15 factors compared between the two stocks.

Remove Ads
Get Oaktree Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for OAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OAC vs. The Competition

MetricOaktree AcquisitionOffices & Clinics Of Medical Doctors IndustryMedical SectorNYSE Exchange
Market Cap$873.17M$1.16B$5.62B$19.10B
Dividend YieldN/AN/A4.89%3.78%
P/E RatioN/A15.2423.7732.75
Price / SalesN/A1.16380.8226.88
Price / Cash377.4536.0138.0517.55
Price / Book173.559.106.854.50
Net Income$1.15M-$52.07M$3.19B$1.02B

Oaktree Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OAC
Oaktree Acquisition
N/A$34.71
+0.7%
N/A+138.2%$873.17MN/A0.00N/AHigh Trading Volume
TDOC
Teladoc Health
3.2693 of 5 stars
$9.44
-1.3%
$11.26
+19.3%
-42.3%$1.63B$2.57B-1.645,600
AUNA
Auna
3.7597 of 5 stars
$7.71
-10.7%
$13.53
+75.5%
N/A$569.54M$4.34B0.0014,958News Coverage
SBC
SBC Medical Group
N/A$4.60
-6.1%
N/AN/A$473.90M$223.34M0.00N/AHigh Trading Volume
AIRS
AirSculpt Technologies
1.2875 of 5 stars
$4.05
-10.6%
$5.00
+23.5%
-49.8%$234.42M$188.78M-28.93240Upcoming Earnings
News Coverage
LFMD
LifeMD
1.9777 of 5 stars
$4.73
-10.1%
$11.14
+135.6%
-29.9%$204.87M$193.06M-7.39230Earnings Report
Analyst Forecast
Short Interest ↑
News Coverage
Gap Up
High Trading Volume
TOI
Oncology Institute
0.6996 of 5 stars
$0.72
-15.0%
N/A-61.8%$54.71M$378.93M-0.93660
SHLT
SHL Telemedicine
1.7439 of 5 stars
$2.43
-2.8%
$11.00
+352.5%
-61.9%$39.85M$55.94M0.00583News Coverage
Gap Down
CCM
Concord Medical Services
0.5524 of 5 stars
$5.07
-2.3%
N/A+4.7%$22.53M$471.70M0.00970Short Interest ↑
News Coverage
Gap Up
HIMS
Hims & Hers Health
2.4936 of 5 stars
$40.65
-9.8%
$37.23
-8.4%
+139.6%$9.03B$1.48B92.391,046
SWTX
SpringWorks Therapeutics
2.8315 of 5 stars
$53.28
-7.8%
$73.20
+37.4%
+5.1%$3.99B$191.59M-15.31230Short Interest ↓
Remove Ads

Related Companies and Tools


This page (NYSE:OAC) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners